Nass M M
Biochim Biophys Acta. 1981 Sep 28;655(2):210-20. doi: 10.1016/0005-2787(81)90011-3.
This study compares over 70 recognition sites for restriction endonucleases on mtDNAs from various control versus malignant cells, derived from Syrian hamster, chick embryo, viper and human cells, exhibiting a wide spectrum of cellular transformation and tumor histories. Agents for transformation in vitro and in vivo include Rous sarcoma viruses, simian virus 40, polyoma virus and adenovirus. The results show a striking intraspecific sequence homogeneity of different mtDNAs regardless of tissue origin and oncogenic history. mtDNA from human biopsy specimens of tumor versus pathologically normal areas yielded indistinguishable restriction cleavage patterns reflecting either the "wild-type' form (with seven restriction endonucleases) or, in one individual, a variant pattern detected with HpaI. The precise position of the HpaI variant site was determined on the physical map of human mtDNA. Additional cleavage sites in the previously reported restriction map of Syrian hamster mtDNA are also presented. It is concluded that (1) mtDNA sequence in higher animal cells are highly conserved in malignant transformation; (2) no evidence for integration of viral sequences in mtDNA is apparent; (3) variant patterns in mtDNA are likely to be intraspecific polymorphisms that pre-exist neoplastic transformation. The possibility is discussed that altered regulatory interaction with the mitochondrial genome, rather than evident changes in mtDNA primary structure, determine anomalous mitochondrial functions in malignant transformation.
本研究比较了来自叙利亚仓鼠、鸡胚、蝰蛇和人类细胞的各种对照细胞与恶性细胞线粒体DNA(mtDNA)上70多个限制性内切酶识别位点,这些细胞呈现出广泛的细胞转化和肿瘤发生史。体内外转化因子包括劳氏肉瘤病毒、猿猴病毒40、多瘤病毒和腺病毒。结果显示,不同的mtDNA具有显著的种内序列同源性,无论其组织来源和致癌史如何。来自人类肿瘤活检标本与病理正常区域的mtDNA产生了难以区分的限制性酶切图谱,反映出“野生型”形式(用七种限制性内切酶),或者在一个个体中,用HpaI检测到的一种变异图谱。在人类mtDNA的物理图谱上确定了HpaI变异位点的精确位置。还展示了叙利亚仓鼠mtDNA先前报道的限制性图谱中的其他酶切位点。得出的结论是:(1)高等动物细胞中的mtDNA序列在恶性转化过程中高度保守;(2)没有明显证据表明病毒序列整合到mtDNA中;(3)mtDNA中的变异图谱可能是肿瘤转化前就已存在的种内多态性。讨论了一种可能性,即与线粒体基因组改变的调节相互作用,而非mtDNA一级结构的明显变化,决定了恶性转化中线粒体功能的异常。